I like that some centres will be in the USA.
Maybe the USA patients will show significant improvement in PMD and the rest of the world patients won't and all regulators will be happy.
Ann: Global Phase 3 Trial of Presendin to Launch in Q4 2021, page-6
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
9.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.914M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5434 | 8.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.5¢ | 99600 | 1 |
View Market Depth
| Last trade - 16.21pm 07/08/2025 (20 minute delay) ? |
| IXC (ASX) Chart |
Day chart unavailable